Stammdaten
BioLife Solutions, Inc. entwickelt, fertigt und liefert Bioproduktionsgeräte und -dienstleistungen für die Zell- und Gentherapie-Industrie in den Vereinigten Staaten, Kanada, Europa, dem Nahen Osten, Afrika und international. Die Produkte des Unternehmens werden in der Grundlagenforschung, angewandten Forschung und kommerziellen Herstellung biologischer Therapien verwendet. Es bietet patentierte Biokonservierungsmedium-Produkte an, einschließlich HypoThermosol FRS und CryoStor, die formuliert sind, um Konservierungsschäden und verzögerte Zellzerstörung zu mindern; und die ThawSTAR-Produktlinie, die automatisierte Auftau-Geräte für Vials und Kryobeutel mit Kontrolle von Wärmezufuhr und Timing des Auftauprozesses biologischer Materialien enthält. Das Unternehmen bietet auch evo Versandcontainer, die Cloud-verbundene passive Lager- und Transportcontainer für temperaturempfindliche Biologika und Arzneimittel sind; Flüssigstickstoff-Laborgefriergeräte, kryogene Ausrüstung und Zubehör; und biologische und pharmazeutische Lagerdienste. Es vermarktet und verkauft seine Produkte direkt sowie durch Drittanbieter-Vertriebspartner. BioLife Solutions, Inc. wurde 1987 gegründet und hat seinen Sitz in Bothell, Washington. KI
Unternehmen & Branche
| Name | BIOLIFE SOLUTIONS INC |
|---|---|
| Ticker | BLFS |
| CIK | 0000834365 |
| Börse | Nasdaq |
| Sektor | Gesundheit |
| Industrie | Medizintechnik |
| SIC | 3845 · Electromedical & Electrotherapeutic Apparatus |
Wertpapier & Kennzahlen
| CUSIP | 09062W204 |
|---|---|
| ISIN | US09062W2044 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,45 Mrd. USD |
| Beta | 1,91 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 3303 MONTE VILLA PARKWAY SUITE 310, 98021 BOTHELL, WA |
| Telefon | 4254011400 |
| EIN (IRS) | 94-3076866 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
| Frühere Namen | CRYOMEDICAL SCIENCES INC (bis 2002) |
Bewertung
| KBV (P/B) | 3,89 vs. 3,26 (2021) ▲ |
|---|---|
| FCF-Rendite | 0,7 % vs. -0,8 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -1,2 % vs. -1,8 % (2021) ▲ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 3,26 | 2,14 | 2,17 | 3,49 | 3,13 | 3,88 | |
| EV/EBITDA | – | 943,4 | – | 1.692,8 | – | – | |
| FCF-Rendite | -0,8 % | -2,4 % | -2,6 % | 0,4 % | 0,9 % | 0,6 % | |
| Qualität & Bilanz | |||||||
| ROIC | -1,8 % | -34,3 % | -18,2 % | -5,3 % | -1,2 % | -0,8 % | |
| Nettoverschuldung/EBITDA | – | 28,5 | – | -90,0 | – | – | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
Score-Verlauf (90 Tage)
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 26.81 | +11.1 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 24.31 | +22.5 % vs SMA200 | |
| SMA-Cross | Bullisch | 10 % | GOLDEN | vor 19 Tagen @ 28.30 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 28.89 | EMA50: 26.99 | |
| MACD-Histogramm | Bullisch | 10 % | 0.025 | Bullisch | |
| RSI(14) | Neutral | 10 % | 58.9 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 53.5 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 46.3 | +DI: 33.0 / −DI: 8.6 | |
| Z-Score(60) | Neutral | 5 % | 1.33 | In Range | |
| 52W-Position | Bullisch | 5 % | 89.5 % | Hoch 31.15 / Tief 18.15 | |
| Bollinger(20,2σ) | Neutral | 5 % | 72.0 % | Upper 30.93 / Mid 28.89 / Lower 26.84 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.1544 | R²=0.86 / annualisiert +149.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | Casdin Partners Master Fund, L.P. | 10% Owner | Open Market Sale | -650.000 | 23,70 | -15.405.000,00 | -1243,7% | |
| 2026-05-20 | Casdin Partners Master Fund, L.P. | 10% Owner | Open Market Sale | -250.000 | 23,70 | -5.925.000,00 | -478,3% | |
| 2026-05-19 | Casdin Partners Master Fund, L.P. | 10% Owner | Open Market Sale | -300.000 | 22,65 | -6.795.000,00 | -548,6% | |
| 2026-03-23 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -2.577 | 19,17 | -49.401,09 | -4,0% | |
| 2026-03-09 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -500 | 20,00 | -10.000,00 | -0,8% | |
| 2026-03-05 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -96.923 | 20,15 | -1.952.998,45 | -157,7% | |
| 2026-03-03 | Werner Sean | Officer, Chief Technology Officer | Open Market Sale | -111 | 20,74 | -2.302,14 | -0,2% | |
| 2026-03-03 | Mathew Aby J. | Officer, EVP & Chief Scientific Officer | Open Market Sale | -529 | 20,74 | -10.971,46 | -0,9% | |
| 2026-03-03 | Wichterman Troy | Officer, Chief Financial Officer | Open Market Sale | -588 | 20,74 | -12.195,12 | -1,0% | |
| 2026-03-03 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -219 | 20,74 | -4.542,06 | -0,4% | |
| 2026-03-03 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -418 | 20,74 | -8.669,32 | -0,7% | |
| 2026-03-03 | Berard Todd | Officer, Chief Marketing Officer | Open Market Sale | -353 | 20,74 | -7.321,22 | -0,6% | |
| 2026-01-06 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -241 | 25,59 | -6.167,19 | -0,5% | |
| 2026-01-06 | Mathew Aby J. | Officer, EVP & Chief Scientific Officer | Open Market Sale | -405 | 25,59 | -10.363,95 | -0,8% | |
| 2026-01-06 | Wichterman Troy | Officer, Chief Financial Officer | Open Market Sale | -990 | 25,59 | -25.334,10 | -2,0% | |
| 2026-01-06 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -335 | 25,59 | -8.572,65 | -0,7% | |
| 2026-01-06 | Berard Todd | Officer, Chief Marketing Officer | Open Market Sale | -344 | 25,59 | -8.802,96 | -0,7% | |
| 2025-12-15 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -713 | 24,46 | -17.439,98 | -1,4% | |
| 2025-12-15 | DuRoss Amy | Director | Open Market Sale | -2.000 | 24,60 | -49.200,00 | -4,0% | |
| 2025-12-09 | Berard Todd | Officer, Chief Marketing Officer | Open Market Sale | -358 | 25,13 | -8.996,54 | -0,7% | |
| 2025-12-09 | Wichterman Troy | Officer, Chief Financial Officer | Open Market Sale | -1.033 | 25,13 | -25.959,29 | -2,1% | |
| 2025-12-09 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -233 | 25,13 | -5.855,29 | -0,5% | |
| 2025-12-09 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -519 | 25,13 | -13.042,47 | -1,1% | |
| 2025-12-09 | Mathew Aby J. | Officer, EVP & Chief Scientific Officer | Open Market Sale | -631 | 25,13 | -15.857,03 | -1,3% | |
| 2025-12-04 | Wichterman Troy | Officer, Chief Financial Officer | Open Market Sale | -30.000 | 25,72 | -771.600,00 | -62,3% | |
| 2025-11-26 | DuRoss Amy | Director | Open Market Sale | -2.000 | 27,00 | -54.000,00 | -4,4% | |
| 2025-11-25 | Wichterman Troy | Officer, Chief Financial Officer | Open Market Sale | -584 | 26,74 | -15.616,16 | -1,3% | |
| 2025-11-25 | Berard Todd | Officer, Chief Marketing Officer | Open Market Sale | -351 | 26,74 | -9.385,74 | -0,8% | |
| 2025-11-25 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -415 | 26,74 | -11.097,10 | -0,9% | |
| 2025-11-25 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -217 | 26,74 | -5.802,58 | -0,5% | |
| 2025-11-25 | DuRoss Amy | Director | Open Market Sale | -2.000 | 27,00 | -54.000,00 | -4,4% | |
| 2025-11-25 | Werner Sean | Officer, Chief Technology Officer | Open Market Sale | -110 | 26,74 | -2.941,40 | -0,2% | |
| 2025-11-25 | Mathew Aby J. | Officer, EVP & Chief Scientific Officer | Open Market Sale | -526 | 26,74 | -14.065,24 | -1,1% | |
| 2025-11-21 | DuRoss Amy | Director | Open Market Sale | -1.000 | 26,00 | -26.000,00 | -2,1% | |
| 2025-11-20 | DuRoss Amy | Director | Open Market Sale | -4.523 | 24,51 | -110.858,73 | -9,0% | |
| 2025-11-19 | DuRoss Amy | Director | Open Market Sale | -477 | 24,50 | -11.686,50 | -0,9% | |
| 2025-11-13 | DE GREEF RODERICK | Director, Officer, President and CEO | Open Market Sale | -31.165 | 25,33 | -789.409,45 | -63,7% | |
| 2025-11-12 | DE GREEF RODERICK | Director, Officer, President and CEO | Open Market Sale | -33.418 | 25,88 | -864.857,84 | -69,8% | |
| 2025-11-11 | DE GREEF RODERICK | Director, Officer, President and CEO | Open Market Sale | -35.417 | 26,15 | -926.154,55 | -74,8% | |
| 2025-10-24 | GOSWAMI JOYDEEP | Director | Open Market Sale | -1.666 | 28,99 | -48.297,34 | -3,9% | |
| 2025-10-22 | DE GREEF RODERICK | Director, Officer, President and CEO | Open Market Sale | -37.795 | 27,30 | -1.031.803,50 | -83,3% | |
| 2025-10-20 | Werner Sean | Officer, Chief Technology Officer | Open Market Sale | -275 | 27,82 | -7.650,50 | -0,6% | |
| 2025-10-16 | GOSWAMI JOYDEEP | Director | Open Market Sale | -1.334 | 0,00 | 0,00 | 0,0% | |
| 2025-10-15 | Casdin Partners Master Fund, L.P. | 10% Owner | Open Market Sale | -750.000 | 28,55 | -21.410.325,00 | -1728,5% | |
| 2025-10-09 | Wichterman Troy | Officer, Chief Financial Officer | Open Market Sale | -833 | 27,36 | -22.790,88 | -1,8% | |
| 2025-10-09 | Mathew Aby J. | Officer, EVP & Chief Scientific Officer | Open Market Sale | -509 | 27,36 | -13.926,24 | -1,1% | |
| 2025-10-09 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -188 | 27,36 | -5.143,68 | -0,4% | |
| 2025-10-09 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -419 | 27,36 | -11.463,84 | -0,9% | |
| 2025-10-09 | Berard Todd | Officer, Chief Marketing Officer | Open Market Sale | -289 | 27,36 | -7.907,04 | -0,6% | |
| 2025-09-15 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -714 | 25,61 | -18.285,54 | -1,5% | |
| 2025-09-11 | Werner Sean | Officer, Chief Technology Officer | Open Market Sale | -72 | 26,83 | -1.931,76 | -0,2% | |
| 2025-09-11 | Mathew Aby J. | Officer, EVP & Chief Scientific Officer | Open Market Sale | -630 | 26,83 | -16.902,90 | -1,4% | |
| 2025-09-11 | Wichterman Troy | Officer, Chief Financial Officer | Open Market Sale | -1.032 | 26,83 | -27.688,56 | -2,2% | |
| 2025-09-11 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -511 | 26,83 | -13.710,13 | -1,1% | |
| 2025-09-11 | Berard Todd | Officer, Chief Marketing Officer | Open Market Sale | -358 | 26,83 | -9.605,14 | -0,8% | |
| 2025-09-11 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -233 | 26,83 | -6.251,39 | -0,5% | |
| 2025-08-26 | Aebersold Sarah | Officer, Chief Human Resources Officer | Open Market Sale | -219 | 25,44 | -5.571,36 | -0,4% | |
| 2025-08-26 | Foster Karen A. | Officer, Chief Quality and Operations | Open Market Sale | -413 | 25,44 | -10.506,72 | -0,8% | |
| 2025-08-26 | Berard Todd | Officer, Chief Marketing Officer | Open Market Sale | -354 | 25,44 | -9.005,76 | -0,7% | |
| 2025-08-26 | Wichterman Troy | Officer, Chief Financial Officer | Open Market Sale | -590 | 25,44 | -15.009,60 | -1,2% | |
| 2025-08-26 | Mathew Aby J. | Officer, EVP & Chief Scientific Officer | Open Market Sale | -531 | 25,44 | -13.508,64 | -1,1% | |
| 2025-08-26 | Werner Sean | Officer, Chief Technology Officer | Open Market Sale | -111 | 25,44 | -2.823,84 | -0,2% | |
| 2025-08-25 | Berard Todd | Officer, Chief Marketing Officer | Open Market Sale | -10.000 | 25,53 | -255.300,00 | -20,6% | |
| 2025-08-15 | Casdin Partners Master Fund, L.P. | 10% Owner | Open Market Sale | -500.000 | 24,40 | -12.200.000,00 | -984,9% | |
| 2025-08-11 | Casdin Partners Master Fund, L.P. | 10% Owner | Open Market Sale | -500.000 | 22,60 | -11.300.000,00 | -912,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 6.101.765 | 0 | 6.101.765 | 116.421.676 | Neu | +100,0% | |
| Casdin Capital, LLC | 5.957.165 | 0 | 5.957.165 | 113.662.708 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.917.708 | 0 | 1.917.708 | 36.589.869 | Neu | +100,0% | |
| STATE STREET CORP | 1.577.076 | 0 | 1.577.076 | 30.090.610 | Neu | +100,0% | |
| FMR LLC | 1.470.252 | 0 | 1.470.252 | 28.052.403 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.197.257 | 0 | 1.197.257 | 22.843.664 | Neu | +100,0% | |
| FRED ALGER MANAGEMENT, LLC | 1.079.935 | 0 | 1.079.935 | 20.605.160 | Neu | +100,0% | |
| Stephens Investment Management Group LLC | 708.666 | 673.129 | 35.537 | 20.012.728 | Aufgestockt | +5,3% | |
| DIMENSIONAL FUND ADVISORS LP | 1.035.757 | 0 | 1.035.757 | 19.761.054 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 971.927 | 0 | 971.927 | 18.547.509 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 904.103 | 0 | 904.103 | 17.250.285 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 901.138 | 0 | 901.138 | 17.193.714 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 885.298 | 0 | 885.298 | 16.891.000 | Neu | +100,0% | |
| PALISADE CAPITAL MANAGEMENT, LP | 758.659 | 0 | 758.659 | 14.475.214 | Neu | +100,0% | |
| Rockefeller Capital Management L.P. | 741.352 | 0 | 741.352 | 14.144.995 | Neu | +100,0% | |
| GENEVA CAPITAL MANAGEMENT LLC | 739.803 | 0 | 739.803 | 14.115.440 | Neu | +100,0% | |
| Granahan Investment Management, LLC | 722.057 | 0 | 722.057 | 13.776.848 | Neu | +100,0% | |
| CRAMER ROSENTHAL MCGLYNN LLC | 632.812 | 0 | 632.812 | 12.074.053 | Neu | +100,0% | |
| ROYCE & ASSOCIATES LP | 584.011 | 0 | 584.011 | 11.142.930 | Neu | +100,0% | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 572.729 | 0 | 572.729 | 10.927.669 | Neu | +100,0% | |
| GAGNON SECURITIES LLC | 536.512 | 0 | 536.512 | 10.236.649 | Neu | +100,0% | |
| PEREGRINE CAPITAL MANAGEMENT LLC | 325.382 | 341.847 | -16.465 | 9.188.788 | Reduziert | -4,8% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 302.318 | 298.618 | 3.700 | 8.537.460 | Aufgestockt | +1,2% | |
| MORGAN STANLEY | 444.228 | 0 | 444.228 | 8.475.889 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 442.508 | 0 | 442.508 | 8.443.052 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 444.041 | 0 | 444.041 | 8.355.788 | Neu | +100,0% | |
| Curi Capital, LLC | 426.015 | 0 | 426.015 | 8.128.367 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 403.485 | 0 | 403.485 | 7.698.494 | Neu | +100,0% | |
| NEXT CENTURY GROWTH INVESTORS LLC | 361.940 | 0 | 361.940 | 6.905.815 | Neu | +100,0% | |
| Summit Creek Advisors LLC | 309.350 | 0 | 309.350 | 5.902.398 | Neu | +100,0% | |
| Gagnon Advisors, LLC | 274.217 | 0 | 274.217 | 5.232.060 | Neu | +100,0% | |
| Ranger Investment Management, L.P. | 269.365 | 0 | 269.365 | 5.139.484 | Neu | +100,0% | |
| Russell Investments Group, Ltd. | 268.225 | 0 | 268.225 | 5.117.742 | Neu | +100,0% | |
| UBS Group AG | 265.978 | 0 | 265.978 | 5.074.861 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 265.487 | 0 | 265.487 | 5.065.492 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 244.172 | 0 | 244.172 | 4.658.802 | Neu | +100,0% | |
| ENVESTNET ASSET MANAGEMENT INC | 242.439 | 0 | 242.439 | 4.625.736 | Neu | +100,0% | |
| Heights Point Management, LP | 232.978 | 0 | 232.978 | 4.445.220 | Neu | +100,0% | |
| ISTHMUS PARTNERS, LLC | 140.987 | 137.952 | 3.035 | 3.981.473 | Aufgestockt | +2,2% | |
| RENAISSANCE TECHNOLOGIES LLC | 207.128 | 0 | 207.128 | 3.952.002 | Neu | +100,0% | |
| TD ASSET MANAGEMENT INC | 193.348 | 0 | 193.348 | 3.689.080 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 190.866 | 0 | 190.866 | 3.641.723 | Neu | +100,0% | |
| Uniplan Investment Counsel, Inc. | 182.837 | 0 | 182.837 | 3.488.543 | Neu | +100,0% | |
| Conestoga Capital Advisors, LLC | 121.652 | 92.472 | 29.180 | 3.435.452 | Aufgestockt | +31,6% | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 139.513 | 0 | 139.513 | 2.661.908 | Neu | +100,0% | |
| STATE OF WISCONSIN INVESTMENT BOARD | 118.645 | 0 | 118.645 | 2.263.747 | Neu | +100,0% | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 111.592 | 0 | 111.592 | 2.129.000 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 110.791 | 0 | 110.791 | 2.113.872 | Neu | +100,0% | |
| Nuveen, LLC | 109.182 | 0 | 109.182 | 2.083.192 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 101.870 | 0 | 101.870 | 1.943.680 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| Stephens Investment Management Group LLC | 708.666 | 673.129 | +5,3% | 20.012.728 | 39,67 | 0 % | 17 Q |
| PEREGRINE CAPITAL MANAGEMENT LLC | 325.382 | 341.847 | -4,8% | 9.188.788 | 18,21 | 37 % | 17 Q |
| NEW YORK STATE COMMON RETIREMENT FUND | 302.318 | 298.618 | +1,2% | 8.537.460 | 16,92 | 100 % | 17 Q |
| ISTHMUS PARTNERS, LLC | 140.987 | 137.952 | +2,2% | 3.981.473 | 7,89 | 100 % | 17 Q |
| Conestoga Capital Advisors, LLC | 121.652 | 92.472 | +31,6% | 3.435.452 | 6,81 | 76 % | 17 Q |
| Penbrook Management LLC | 39.705 | 23.155 | +71,5% | 1.121.269 | 2,22 | 0 % | 16 Q |
| D.A. DAVIDSON & CO. | 33.952 | 33.317 | +1,9% | 958.804 | 1,90 | 100 % | 14 Q |
| Louisiana State Employees Retirement System | 17.300 | 17.300 | 0,0% | 488.552 | 0,97 | 100 % | 17 Q |
| Kings Path Partners LLC | 16.570 | 16.570 | 0,0% | 467.937 | 0,93 | 0 % | 9 Q |
| NorthCrest Asset Manangement, LLC | 14.876 | 14.843 | +0,2% | 419.949 | 0,83 | 0 % | 17 Q |
| Police & Firemen's Retirement System of New Jersey | 12.175 | 10.459 | +16,4% | 343.822 | 0,68 | 100 % | 7 Q |
| YOUSIF CAPITAL MANAGEMENT, LLC | 10.577 | 10.543 | +0,3% | 298.694 | 0,59 | 24 % | 17 Q |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 9.384 | 0 | +100,0% | 265.004 | 0,53 | 100 % | 11 Q |
| Compagnie Lombard Odier SCmA | 9.000 | 9.000 | 0,0% | 254.160 | 0,50 | 100 % | 17 Q |
| GAMMA Investing LLC | 8.996 | 6.586 | +36,6% | 254.047 | 0,50 | 100 % | 11 Q |
| OREGON PUBLIC EMPLOYEES RETIREMENT FUND | 8.985 | 8.885 | +1,1% | 253.736 | 0,50 | 100 % | 17 Q |
| 1620 INVESTMENT ADVISORS, INC. | 1.979 | 2.274 | -13,0% | 55.887 | 0,11 | 50 % | 9 Q |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 16.162 | 15.659 | +3,2% | 35.496 | 0,07 | 0 % | 4 Q |
| Farther Finance Advisors, LLC | 782 | 771 | +1,4% | 22.084 | 0,04 | 0 % | 11 Q |
| Sterling Capital Management LLC | 723 | 266 | +171,8% | 20.418 | 0,04 | 0 % | 8 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 39 | 1,9 | 51 |
| 31.03.2026 | ✓ | 187 | 52,7 | 877 |
| 31.12.2025 | ✓ | 186 | 50,8 | 1.092 |
| 30.09.2025 | ✓ | 191 | 49,6 | 1.152 |
| 30.06.2025 | ✓ | 191 | 51,0 | 2.393 |
| 31.03.2025 | ✓ | 185 | 51,7 | 2.644 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| CRAMER ROSENTHAL MCGLYNN LLC | 632.812 | 12.074.053 |
| Man Group plc | 72.626 | 1.385.704 |
| Vestmark Advisory Solutions, Inc. | 53.690 | 1.024.405 |
| HSBC HOLDINGS PLC | 45.576 | 873.692 |
| CIBC Bancorp USA Inc. | 39.778 | 758.964 |
| Vident Advisory, LLC | 19.829 | 378.337 |
| EntryPoint Capital, LLC | 15.107 | 288.242 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14.684 | 280.171 |
| Cornerstone Investment Partners, LLC | 14.251 | 271.909 |
| Freestone Grove Partners LP | 5.163 | 98.510 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 6.506.346 | 1.325.522 | +25.6 % | 124.142 |
| BANK OF AMERICA CORP /DE/ | 904.103 | 382.776 | +73.4 % | 17.250.285 |
| Granahan Investment Management, LLC | 722.057 | 239.701 | +49.7 % | 13.776.848 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.197.257 | 193.093 | +19.2 % | 22.843.664 |
| BlackRock, Inc. | 6.101.765 | 190.151 | +3.2 % | 116.421.676 |
| ROYCE & ASSOCIATES LP | 584.011 | 166.921 | +40.0 % | 11.142.930 |
| CITADEL ADVISORS LLC | 244.172 | 146.859 | +150.9 % | 4.658.802 |
| Russell Investments Group, Ltd. | 268.225 | 101.996 | +61.4 % | 5.117.742 |
| NEXT CENTURY GROWTH INVESTORS LLC | 361.940 | 98.969 | +37.6 % | 6.905.815 |
| STATE STREET CORP | 1.577.076 | 71.483 | +4.7 % | 30.090.610 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| MORGAN STANLEY | 444.228 | -90.812 | -17.0 % | 8.475.889 |
| FMR LLC | 1.470.252 | -77.942 | -5.0 % | 28.052.403 |
| D. E. Shaw & Co., Inc. | 101.870 | -64.511 | -38.8 % | 1.943.680 |
| GENEVA CAPITAL MANAGEMENT LLC | 739.803 | -63.735 | -7.9 % | 14.115.440 |
| PALISADE CAPITAL MANAGEMENT, LP | 758.659 | -52.351 | -6.5 % | 14.475.214 |
| WELLS FARGO & COMPANY/MN | 94.762 | -34.208 | -26.5 % | 1.808.059 |
| BARCLAYS PLC | 30.065 | -34.029 | -53.1 % | 573.640 |
| CITIGROUP INC | 21.384 | -19.595 | -47.8 % | 408.006 |
| RENAISSANCE TECHNOLOGIES LLC | 207.128 | -17.572 | -7.8 % | 3.952.002 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 341.847 | -14.496 | -4.1 % | 6.522.441 |
Zusätzlich aktuell von 133 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck | Δ-Balken |
|---|---|---|---|---|---|---|---|
| 05.06.2026 | Casdin Partners Master Fund, L.P. (+3) | Passiv (13G) | 9,70 % | 4.757.165 | 0,00 pp | – | |
| 22.05.2026 | Casdin Partners Master Fund, L.P. (+3) | Aktivist (13D/A) | 9,70 % | 4.757.165 | -2,70 pp | The Reporting Persons have acquired their Shares of the Issuer for investment. The Repo… | |
| 15.05.2026 | T. Rowe Price Investment Management, Inc. | Passiv (13G/A) | 13,50 % | 6.506.346 | +2,70 pp | – | |
| 06.05.2026 | Invesco Ltd. | Passiv (13G/A) | 4,90 % | 2.348.532 | -3,30 pp | – | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -5,71 pp | – | |
| 12.02.2026 | Invesco Ltd. | Passiv (13G/A) | 8,20 % | 3.932.191 | +1,20 pp | – | |
| 08.01.2026 | T. Rowe Price Investment Management, Inc. | Passiv (13G/A) | 10,80 % | 5.180.824 | +1,90 pp | – | |
| 17.10.2025 | Casdin Partners Master Fund, L.P. (+3) | Aktivist (13D/A) | 12,40 % | 5.957.165 | -1,60 pp | The Reporting Persons have acquired their Shares of the Issuer for investment. The Repo… | |
| 21.08.2025 | Casdin Partners Master Fund, L.P. (+3) | Aktivist (13D/A) | 14,00 % | 6.707.165 | -1,00 pp | he Reporting Persons have acquired their Shares of the Issuer for investment. The Repor… | |
| 14.08.2025 | T. Rowe Price Investment Management, Inc. | Passiv (13G) | 8,90 % | 4.246.706 | Neu | – | |
| 13.08.2025 | Casdin Partners Master Fund, L.P. (+3) | Aktivist (13D/A) | 15,00 % | 7.207.165 | -1,20 pp | The Reporting Persons have acquired their Shares of the Issuer for investment. The Repo… | |
| 12.06.2025 | Casdin Partners Master Fund, L.P. (+3) | Aktivist (13D/A) | 16,20 % | 7.707.165 | -2,30 pp | The Reporting Persons have acquired their Shares of the Issuer for investment. The Repo… | |
| 09.04.2025 | Casdin Partners Master Fund, L.P. (+3) | Aktivist (13D/A) | 18,50 % | 8.735.159 | -0,70 pp | The Reporting Persons have acquired their Shares of the Issuer for investment. The Repo… | |
| 08.11.2024 | Invesco Ltd. | Passiv (13G) | 7,00 % | 3.242.364 | Neu | – | |
| 01.11.2024 | THE GOLDMAN SACHS GROUP, INC. (+1) | Passiv (13G/A) | 0,40 % | 161.488 | -5,10 pp | – | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 5,71 % | 2.571.608 | -0,06 pp | – | |
| 02.02.2024 | THE GOLDMAN SACHS GROUP, INC. (+1) | Passiv (13G) | 5,50 % | 2.476.242 | Neu | – | |
| 24.01.2024 | Integrated Core Strategies (US) LLC | Passiv (13G/A) | 5,30 % | 2.404.862 | -0,20 pp | – | |
| 24.01.2024 | Millennium Group Management LLC (+2) | Passiv (13G/A) | 5,40 % | 2.412.650 | -0,30 pp | – | |
| 23.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 12,30 % | 5.424.116 | -0,50 pp | – | |
| 24.10.2023 | Casdin Partners Master Fund, L.P. | Aktivist (13D/A) | 19,20 % | 8.557.165 | -3,50 pp | – | |
| 24.10.2023 | Casdin Partners GP, LLC (+2) | Aktivist (13D/A) | 19,50 % | 8.707.165 | Neu | – | |
| 26.09.2023 | Millennium Group Management LLC (+2) | Passiv (13G) | 5,70 % | 2.481.946 | +4,10 pp | – | |
| 26.09.2023 | Integrated Core Strategies (US) LLC | Passiv (13G) | 5,50 % | 2.406.913 | Neu | – | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 5,77 % | 2.466.931 | +0,61 pp | – | |
| 26.01.2023 | . BlackRock, Inc. | Passiv (13G/A) | 12,80 % | 5.477.126 | 0,00 pp | – | |
| 20.01.2023 | . BlackRock, Inc. | Passiv (13G/A) | 12,80 % | 5.477.126 | +1,30 pp | – | |
| 11.01.2023 | Millennium Group Management LLC (+2) | Passiv (13G/A) | 1,60 % | 670.202 | -3,50 pp | – | |
| 08.07.2022 | . BlackRock, Inc. | Passiv (13G) | 11,50 % | 4.893.203 | +2,70 pp | – | |
| 22.06.2022 | Millennium Group Management LLC (+2) | Passiv (13G) | 5,10 % | 2.166.344 | Neu | – | |
| 09.02.2022 | The Vanguard Group | Passiv (13G) | 5,16 % | 2.147.258 | Neu | – | |
| 01.02.2022 | . BlackRock, Inc. | Passiv (13G/A) | 8,80 % | 3.655.057 | -2,30 pp | – | |
| 01.11.2021 | Walter Villiger (+1) | Aktivist (13D/A) | 4,86 % | 1.979.226 | -2,54 pp | – | |
| 09.09.2021 | . BlackRock, Inc. | Passiv (13G) | 11,10 % | 4.528.723 | Neu | – |
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | 1.186.000 $ | 0,02 $ | 400.906.000 $ | 372.230.000 $ |
| 2025-12-31 | 10-K | – | -4.595.000 $ | -0,10 $ | 405.884.000 $ | 371.888.000 $ |
| 2025-09-30 | 10-Q | – | 621.000 $ | 0,01 $ | 392.081.000 $ | 353.739.000 $ |
| 2025-06-30 | 10-Q | – | -15.838.000 $ | -0,33 $ | 387.240.000 $ | 347.155.000 $ |
| 2025-03-31 | 10-Q | – | -448.000 $ | 0,00 $ | 395.141.000 $ | 352.624.000 $ |
| 2024-12-31 | 10-K | – | -20.184.000 $ | -0,44 $ | 399.487.000 $ | 348.909.000 $ |
| 2024-09-30 | 10-Q | – | -1.703.000 $ | -0,04 $ | 381.652.000 $ | 325.461.000 $ |
| 2024-06-30 | 10-Q | – | -20.719.000 $ | -0,45 $ | 374.976.000 $ | 321.442.000 $ |
| 2024-03-31 | 10-Q | – | -10.221.000 $ | -0,22 $ | 401.602.000 $ | 333.405.000 $ |
| 2023-12-31 | 10-K | – | -68.002.000 $ | -1,55 $ | 412.714.000 $ | 337.663.000 $ |
| 2023-09-30 | 10-Q | – | -29.132.000 $ | -0,67 $ | 411.152.000 $ | 332.017.000 $ |
| 2023-06-30 | 10-Q | – | -10.199.000 $ | -0,23 $ | 433.177.000 $ | 352.128.000 $ |
| 2023-03-31 | 10-Q | – | -13.714.000 $ | -0,32 $ | 446.470.000 $ | 358.107.000 $ |
| 2022-12-31 | 10-K | – | -139.805.000 $ | -3,25 $ | 450.229.000 $ | 364.188.000 $ |
| 2022-09-30 | 10-Q | – | -10.317.000 $ | -0,24 $ | 488.020.000 $ | 405.120.000 $ |
| 2022-06-30 | 10-Q | – | -72.878.000 $ | -1,72 $ | 470.681.000 $ | 409.544.000 $ |
| 2022-03-31 | 10-Q | – | -7.421.000 $ | – | 544.279.000 $ | 476.075.000 $ |
| 2021-12-31 | 10-K | – | -8.908.000 $ | -0,23 $ | 554.286.000 $ | 478.047.000 $ |
| 2021-09-30 | 10-Q | – | 79.000 $ | 0,00 $ | 559.391.000 $ | 489.259.000 $ |
| 2021-06-30 | 10-Q | – | 7.876.000 $ | 0,19 $ | 520.969.000 $ | 452.281.000 $ |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Product | 76,0 Mio. | 117,7 Mio. | 136,0 Mio. | 101,9 Mio. | 44,5 Mio. | 46,2 % | -35,4% | |
| Product Cell Processing | 73,4 Mio. | 65,8 Mio. | 68,5 Mio. | 45,0 Mio. | – | 44,6 % | +11,7% | |
| Rental Evo And Thaw | 6,1 Mio. | – | – | – | – | 3,7 % | Neu | |
| Rental Revenue | 6,1 Mio. | 8,0 Mio. | 10,5 Mio. | 7,4 Mio. | 1,8 Mio. | 3,7 % | -24,4% | |
| Product Evo And Thaw | 2,6 Mio. | – | – | – | – | 1,6 % | Neu | |
| Service Evo And Thaw | 160.000 | – | – | – | – | 0,1 % | Neu | |
| Service | 160.000 | 17,6 Mio. | – | – | – | 0,1 % | -99,1% | |
| Product Freezer And Thaw | – | 50,6 Mio. | 66,7 Mio. | 56,6 Mio. | – | – | – | |
| Service Biostorage Services | – | 16,5 Mio. | – | – | – | – | – | |
| Rental Biostorage Services | – | 8,0 Mio. | – | – | – | – | – | |
| Product Biostorage Services | – | 1,3 Mio. | – | – | – | – | – | |
| Service Freezer And Thaw | – | 1,0 Mio. | 74.000 | – | – | – | – | |
| Service Revenue | – | – | 15,3 Mio. | 9,8 Mio. | 1,8 Mio. | – | – | |
| Service Storage And Cold Chain Services | – | – | 15,2 Mio. | 9,8 Mio. | – | – | – | |
| Rental Storage And Cold Chain Services | – | – | 10,5 Mio. | 7,4 Mio. | – | – | – | |
| Product Storage And Cold Chain Services | – | – | 809.000 | 328.000 | – | – | – | |
| Biopreservation Media | – | – | – | – | 30,9 Mio. | – | – | |
| Freezers And Accessories | – | – | – | – | 11,8 Mio. | – | – | |
| Rental Revenue From Cold Chain Management | – | – | – | – | 1,8 Mio. | – | – | |
| Biological And Pharmaceutical Storage | – | – | – | – | 1,8 Mio. | – | – | |
| Automated Thawing Products | – | – | – | – | 1,7 Mio. | – | – | |
| Product Revenue From Cold Chain Management | – | – | – | – | 46.000 | – | – |
Quartalsverlauf
| Segment | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Product | 26,3 Mio. | 23,7 Mio. | 22,3 Mio. | 23,5 Mio. | 21,3 Mio. | 24,8 Mio. | 46,8 % | +11,9% | |
| Product Cell Processing | 25,3 Mio. | 22,9 Mio. | 21,6 Mio. | 19,0 Mio. | 17,9 Mio. | 16,2 Mio. | 45,0 % | +32,9% | |
| Rental Revenue | 1,8 Mio. | 1,7 Mio. | 1,6 Mio. | 2,5 Mio. | 2,6 Mio. | 1,8 Mio. | 3,2 % | -27,0% | |
| Rental Revenue Evo And Thaw | 1,8 Mio. | 1,7 Mio. | 1,6 Mio. | – | – | – | 3,2 % | Neu | |
| Product Evo And Thaw | 968.000 | 811.000 | 725.000 | – | – | – | 1,7 % | Neu | |
| Service | 26.000 | 36.000 | 60.000 | 4,7 Mio. | 4,4 Mio. | 5,1 Mio. | 0,0 % | -99,4% | |
| Service Evo And Thaw | 26.000 | 36.000 | 60.000 | – | – | – | 0,0 % | Neu | |
| Service Biostorage Services | – | – | – | 4,5 Mio. | 4,2 Mio. | – | – | – | |
| Product Freezer And Thaw | – | – | – | 3,9 Mio. | 3,2 Mio. | 8,3 Mio. | – | – | |
| Rental Revenue Biostorage Services | – | – | – | 2,5 Mio. | 2,6 Mio. | – | – | – | |
| Product Biostorage Services | – | – | – | 543.000 | 144.000 | – | – | – | |
| Service Freezer And Thaw | – | – | – | 134.000 | 210.000 | 113.000 | – | – | |
| Storage And Storage Services | – | – | – | – | – | 5,0 Mio. | – | – | |
| Storage And Storage Services Rental Revenue | – | – | – | – | – | 1,8 Mio. | – | – | |
| Storage And Storage Services Product Revenue | – | – | – | – | – | 283.000 | – | – |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | – | 0,02 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | – | 0,01 |
| Q2 2025 | 30.06.2025 | 07.08.2025 | – | -0,33 |
| Q1 2025 | 31.03.2025 | 08.05.2025 | – | 0,00 |
| Q3 2024 | 30.09.2024 | 12.11.2024 | – | -0,04 |
| Q2 2024 | 30.06.2024 | 09.08.2024 | – | -0,45 |
| Q1 2024 | 31.03.2024 | 10.05.2024 | – | -0,22 |
| Q3 2023 | 30.09.2023 | 09.11.2023 | – | -0,67 |
| Q2 2023 | 30.06.2023 | 09.08.2023 | – | -0,23 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | 31.03.2026 | 37 Tage | SEC » |
| 28.04.2026 | 10-K/A | 31.12.2025 | 118 Tage | SEC » |
| 26.02.2026 | 10-K | 31.12.2025 | 57 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 08.04.2025 | 10-K/A | 31.12.2024 | 98 Tage | SEC » |
| 03.03.2025 | 10-K | 31.12.2024 | 62 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
| 09.08.2024 | 10-Q | 30.06.2024 | 40 Tage | SEC » |
| 10.05.2024 | 10-Q | 31.03.2024 | 40 Tage | SEC » |
| 29.02.2024 | 10-K | 31.12.2023 | 60 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 09.08.2023 | 10-Q | 30.06.2023 | 40 Tage | SEC » |
| 11.05.2023 | 10-Q | 31.03.2023 | 41 Tage | SEC » |
| 31.03.2023 | 10-K | 31.12.2022 | 90 Tage | SEC » |
| 09.11.2022 | 10-Q | 30.09.2022 | 40 Tage | SEC » |
| 09.08.2022 | 10-Q | 30.06.2022 | 40 Tage | SEC » |
| 10.05.2022 | 10-Q | 31.03.2022 | 40 Tage | SEC » |
| 31.03.2022 | 10-K | 31.12.2021 | 90 Tage | SEC » |
| 15.11.2021 | 10-Q | 30.09.2021 | 46 Tage | SEC » |
| 16.08.2021 | 10-Q | 30.06.2021 | 47 Tage | SEC » |
| 17.05.2021 | 10-Q | 31.03.2021 | 47 Tage | SEC » |
| 31.03.2021 | 10-K | 31.12.2020 | 90 Tage | SEC » |
| 09.11.2020 | 10-Q | 30.09.2020 | 40 Tage | SEC » |
| 10.08.2020 | 10-Q | 30.06.2020 | 41 Tage | SEC » |
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 08.07.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 08.07.2025 | HV-Einladung | 20.08.2025 Jahres-HV | 23.06.2025 | DEF 14A | SEC » |
| 26.07.2024 | HV-Einladung | — | — | DEFA14A | SEC » |
| 05.06.2024 | HV-Einladung | 01.08.2024 Jahres-HV | 03.06.2024 | DEF 14A | SEC » |
| 06.06.2023 | HV-Einladung | 21.07.2023 Jahres-HV | 24.05.2023 | DEF 14A | SEC » |
| 29.04.2022 | HV-Einladung | 09.06.2022 Jahres-HV | 12.04.2022 | DEF 14A | SEC » |
| 30.04.2021 | HV-Einladung | 18.06.2021 Jahres-HV | 23.04.2021 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
Übernahmen & Fusionen (M&A)
M&A-relevante SEC-Filings der letzten sechs Jahre: Übernahmeangebote (Tender Offers), Fusionen (425/S-4), Aktienrückkauf-Angebote (Self-Tender) und Going-Private-Transaktionen. Geführt nach dem einreichenden Emittenten.
| Datum (US) | Kategorie | Form | Deal-Konditionen | SEC |
|---|---|---|---|---|
| 24.07.2026 | Fusion | 425 | Ziel: BioLife Solutions, Inc. · $11,25 Cash + Aktien | SEC » |
| 22.07.2026 | Fusion | 425 | Ziel: BioLife Solutions, Inc. · $11,25 Cash + Aktien | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Deal-Konditionen aus dem Dokument extrahiert (Tender: SC TO-T/-I/SC 14D9; Fusion: 425/S-4 — Gegenpartei + Umtauschverhältnis), ohne Gewähr — Original siehe SEC-Link.
Privatplatzierungen (Reg D)
Reg-D-Privatplatzierungen (Form D) der letzten sechs Jahre — SEC-befreite Kapitalaufnahmen ohne öffentliches Prospekt (z. B. PIPEs, Wandelanleihen an ausgewählte Investoren). Wiederholte Privatplatzierungen können auf laufenden Kapitalbedarf und Verwässerung der Altaktionäre hindeuten.
| Datum (US) | Art | Form | |
|---|---|---|---|
| 27.10.2023 | Privatplatzierung | D | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Nur Metadaten — Emissions-Betrag und Investoren stehen im Dokument (SEC-Link).
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 09.01.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 24.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | o Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 20.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | o Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 23.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | year and the management changes described in Item 5.02 below. A copy of the press release is furnished as Exhibit 99.1… |
| 16.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 06.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 06.10.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 26.08.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 09.11.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.10.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 17.09.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 14.07.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 17.02.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.01.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.12.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 01.12.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 18.05.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 30.04.2020 | Item 4.02 — Bilanzkorrekturen | – | EXTREM | SEC | Item 4.02(a) Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 22.07.2026 | M&A angekündigt | 0,30 | 85 | BioLife Solutions, Inc. meldet Eingang in ein bedeutendes Definitives Abkommen zur Fusion mit Repligen Corporation. Die Transaktion ist erwa… 🔒 | SEC |
| 03.06.2026 | Sonstiges | 0,00 | 15 | BioLife Solutions offenbart Investorenpräsentation zur Verwendung auf Jefferies Global Healthcare Conference und anderen Investorengespräche… 🔒 | SEC |
| 07.05.2026 | Quartalszahlen | 0,00 | 45 | BioLife Solutions veröffentlicht Pressemitteilung mit ungeprüften Finanzergebnissen und operativen Highlights für das erste Quartal 2026. | SEC |
| 02.03.2026 | Sonstiges | 0,00 | 25 | BioLife Solutions Inc. veröffentlichte am 2. März 2026 eine Investor Presentation und stellte diese auf ihrer IR-Website zur Verfügung. | SEC |
| 26.02.2026 | Quartalszahlen | 0,00 | 55 | BioLife Solutions Inc. veröffentlichte Pressemitteilung mit Finanzergebnissen und operativen Highlights für Q4 und Geschäftsjahr 2025. | SEC |
| 12.01.2026 | Quartalszahlen | 0,00 | 70 | BioLife Solutions kündigte am 12.01.2026 vorläufige, nicht geprüfte Umsatzzahlen für Q4 2025 und das Gesamtjahr an. Das Unternehmen veröffen… 🔒 | SEC |
| 09.01.2026 | Personalwechsel | -0,35 | 60 | Chief Quality and Operations Officer Karen Foster kündigt ihren Rücktritt zum 31. März 2026 an. Die Kündigung ist geordnet mit dreimonatiger… 🔒 | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-26 | 40.991 | 27,50 | 1.127.253 |
| 2026-06-22 | 148 | 26,04 | 3.854 |
| 2026-06-18 | 21.524 | 25,58 | 550.584 |
| 2026-06-15 | 730 | 26,10 | 19.053 |
| 2026-06-05 | 114 | 27,09 | 3.088 |
| 2026-06-04 | 241 | 27,25 | 6.567 |
| 2026-06-02 | 686 | 26,63 | 18.268 |
| 2026-05-19 | 3.598 | 22,30 | 80.235 |
| 2026-05-14 | 39 | 21,17 | 826 |
| 2026-05-13 | 66 | 21,23 | 1.401 |
| 2026-05-04 | 620 | 21,21 | 13.150 |
| 2026-04-27 | 598 | 21,38 | 12.785 |
| 2026-04-22 | 871 | 22,37 | 19.484 |
| 2026-04-16 | 1.248 | 21,19 | 26.445 |
| 2026-04-14 | 513 | 20,11 | 10.316 |
| 2026-04-13 | 174 | 19,74 | 3.435 |
| 2026-04-10 | 139 | 20,48 | 2.847 |
| 2026-04-07 | 389 | 19,27 | 7.496 |
| 2026-04-02 | 903 | 19,29 | 17.419 |
| 2026-03-31 | 150 | 18,78 | 2.817 |
| 2026-03-30 | 725 | 18,59 | 13.478 |
| 2026-03-27 | 646 | 19,65 | 12.694 |
| 2026-03-26 | 116 | 19,86 | 2.304 |
| 2026-03-25 | 2.413 | 19,70 | 47.536 |
| 2026-03-20 | 14 | 19,53 | 273 |
| 2026-03-19 | 9 | 19,12 | 172 |
| 2026-03-18 | 1.753 | 19,40 | 34.008 |
| 2026-03-16 | 408 | 18,36 | 7.491 |
| 2026-03-11 | 590 | 18,67 | 11.015 |
| 2026-03-03 | 20 | 22,52 | 450 |
| 2026-02-27 | 28 | 22,48 | 629 |
| 2026-02-24 | 11 | 22,88 | 252 |
| 2026-02-20 | 132 | 23,23 | 3.066 |
| 2026-02-19 | 183 | 22,84 | 4.180 |
| 2026-02-18 | 2.015 | 22,36 | 45.055 |
| 2026-02-17 | 289 | 22,23 | 6.424 |
| 2026-02-12 | 218 | 22,25 | 4.851 |
| 2026-02-11 | 6.424 | 22,65 | 145.504 |
| 2026-02-06 | 3.460 | 22,02 | 76.189 |
| 2026-02-05 | 259 | 22,67 | 5.872 |
| 2026-02-03 | 239 | 22,33 | 5.337 |
| 2026-02-02 | 239 | 21,80 | 5.210 |
| 2026-01-30 | 83 | 22,58 | 1.874 |
Hinweis
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 28.07.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Signal-Komponenten und Gewichte.